These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10905364)

  • 1. Eosinophilic enteritis observed during alpha-interferon therapy for chronic hepatitis C.
    Kakumitsu S; Shijo H; Akiyoshi N; Seo M; Okada M
    J Gastroenterol; 2000; 35(7):548-51. PubMed ID: 10905364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic Enteritis Presenting as Massive Ascites after Influenza A Virus Infection in a Young Female.
    Kim MJ; Oh MJ
    Korean J Gastroenterol; 2019 Sep; 74(3):163-167. PubMed ID: 31554032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist.
    Hayashida S; Sato S; Shimada Y; Tsuzura H; Ikeda Y; Takahashi S; Sato S; Amano N; Murata A; Nagahara A; Genda T
    Intern Med; 2020; 59(16):1977-1981. PubMed ID: 32801271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: a patient who developed an amoebic liver abscess during treatment with interferon.
    Matsuo T; Shinzawa H; Sugahara K; Mitsuhashi H; Watanabe H; Abe T; Ohno S; Terashita M; Saito K; Saito T; Misawa H; Togashi H; Takahashi T
    J Gastroenterol Hepatol; 1998 Oct; 13(10):1068-71. PubMed ID: 9835326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Case of Eosinophilic Enteritis Needed to Distinguish from a Tumor of the Small Intestine].
    Tsujio G; Aomatsu N; Wang E; Yamakoshi Y; Nagashima D; Hirakawa T; Iwauchi T; Nishii T; Morimoto J; Nakazawa K; Tei S; Uchima Y; Takeuchi K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1863-1865. PubMed ID: 28133157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.
    Hoffmann RM; Jung MC; Motz R; Gössl C; Emslander HP; Zachoval R; Pape GR
    J Hepatol; 1998 Jun; 28(6):1058-63. PubMed ID: 9672184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic gastroenteritis in a patient with chronic hepatitis C who received treatment with pegylated interferon.
    Hirano G; Fukunaga A; Sohda T; Kunimoto H; Yotsumoto K; Sakurai K; Iwashita H; Ueda S; Yokoyama K; Morihara D; Tomioka Y; Anan A; Yamaguchi M; Takeyama Y; Eguchi K; Sakamoto M; Irie M; Iwata K; Shakado S; Aoyagi K; Sakisaka S
    Clin J Gastroenterol; 2012 Apr; 5(2):127-30. PubMed ID: 26182155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C.
    Shiffman ML; Hofmann CM; Luketic VA; Sanyal AJ
    J Hepatol; 1998 Mar; 28(3):382-9. PubMed ID: 9551674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.
    Maddrey WC
    Semin Liver Dis; 1999; 19 Suppl 1():67-75. PubMed ID: 10349694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C: an Italian multicenter experience. Ribavirin-Interferon in Chronic Hepatitis Italian Group Investigators.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Pellicelli A; Grisorio B; Barbarini G
    J Hepatol; 2000 Sep; 33(3):448-55. PubMed ID: 11020001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis.
    Dalekos GN; Christodoulou D; Kistis KG; Zervou EK; Hatzis J; Tsianos EV
    Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):933-9. PubMed ID: 9872615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C.
    Gressens B; Gohy P
    Acta Gastroenterol Belg; 2004; 67(3):301-2. PubMed ID: 15587340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial.
    Barbaro G; Di Lorenzo G; Belloni G; Ferrari L; Paiano A; Del Poggio P; Bacca D; Fruttaldo L; Mongiò F; Francavilla R; Scotto G; Grisorio B; Calleri G; Annese M; Barelli A; Rocchetto P; Rizzo G; Gualandi G; Poltronieri I; Barbarini G
    Am J Med; 1999 Aug; 107(2):112-8. PubMed ID: 10460040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group.
    Reichard O; Norkrans G; Frydén A; Braconier JH; Sönnerborg A; Weiland O
    Lancet; 1998 Jan; 351(9096):83-7. PubMed ID: 9439491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid: a randomized prospective trial.
    Abdelmalek MF; Harrison ME; Gross JB; Poterucha JJ; Gossard AA; Spivey JR; Rakela J; Lindor KD
    J Clin Gastroenterol; 1998 Mar; 26(2):130-4. PubMed ID: 9563925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment. Multicenter Study Group under the coordination of the Necker Hospital, Paris, France.
    Pol S; Couzigou P; Bourlière M; Abergel A; Combis JM; Larrey D; Tran A; Moussalli J; Poupon R; Berthelot P; Bréchot C
    J Hepatol; 1999 Jul; 31(1):1-7. PubMed ID: 10424277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alfa for chronic hepatitis C infection.
    Kingsley D
    Lancet; 1999 Feb; 353(9151):499; author reply 500. PubMed ID: 9989746
    [No Abstract]   [Full Text] [Related]  

  • 18. Eosinophilic enteritis presenting as intussusception in adult.
    Shin WG; Park CH; Lee YS; Kim KO; Yoo KS; Kim JH; Park CK
    Korean J Intern Med; 2007 Mar; 22(1):13-7. PubMed ID: 17427639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic anemia provoked by recombinant alpha-interferon.
    Takase K; Nakano T; Hamada M; Shiraki K; Oohashi Y; Kihira T; Tameda Y
    J Gastroenterol; 1995 Dec; 30(6):795-7. PubMed ID: 8963402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
    Kakizaki S; Takagi H; Murakami M; Takayama H; Mori M
    J Hepatol; 1999 May; 30(5):794-800. PubMed ID: 10365804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.